Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Yahoo Finance
2 weeks ago • Google News
OmniAb Inc. (OABI)
US$ 4.01993.87%
Price Chart
Key Statistics
Market Cap
$ 189.62M
P/E Ratio
0.00
Revenue (TTM)
$ 26.74M
Volume
387.77K
52W High
$ 4.96
52W Low
$ 1.35
Dividend Yield
0.00%
Beta
0.92
Technicals
50-Day MA
2.1072
200-Day MA
3.4483
52 Week High
4.96
52 Week Low
1.35
About OABI
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United S.
Employees
114
Headquarters
Emeryville, CA
CEO
Mr. Matthew W. Foehr
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg